"Diphtheria Toxoid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The formaldehyde-inactivated toxin of Corynebacterium diphtheriae. It is generally used in mixtures with TETANUS TOXOID and PERTUSSIS VACCINE; (DTP); or with tetanus toxoid alone (DT for pediatric use and Td, which contains 5- to 10-fold less diphtheria toxoid, for other use). Diphtheria toxoid is used for the prevention of diphtheria; DIPHTHERIA ANTITOXIN is for treatment.
| Descriptor ID |
D004168
|
| MeSH Number(s) |
D20.215.894.691.263
|
| Concept/Terms |
Diphtheria Toxoid- Diphtheria Toxoid
- Toxoid, Diphtheria
- Diphtheria Vaccine
- Vaccine, Diphtheria
|
Below are MeSH descriptors whose meaning is more general than "Diphtheria Toxoid".
Below are MeSH descriptors whose meaning is more specific than "Diphtheria Toxoid".
This graph shows the total number of publications written about "Diphtheria Toxoid" by people in this website by year, and whether "Diphtheria Toxoid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Diphtheria Toxoid" by people in Profiles.
-
Magnitude of interference after diphtheria-tetanus toxoids-acellular pertussis/Haemophilus influenzae type b capsular polysaccharide-tetanus vaccination is related to the number of doses administered. J Infect Dis. 2001 Nov 15; 184(10):1293-9.
-
Vaccine antigen interactions after a combination diphtheria-tetanus toxoid-acellular pertussis/purified capsular polysaccharide of Haemophilus influenzae type b-tetanus toxoid vaccine in two-, four- and six-month-old infants. Pediatr Infect Dis J. 1997 Sep; 16(9):863-70.
-
Interchangeability of Haemophilus influenzae type b vaccines in the primary series: evaluation of a two-dose mixed regimen. Pediatrics. 1996 Nov; 98(5):898-904.
-
Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period. Pediatrics. 1995 Apr; 95(4):522-7.
-
Cost-benefit analysis of Haemophilus influenzae type b prevention: conjugate vaccination at eighteen months of age. Pediatr Infect Dis J. 1990 Apr; 9(4):246-52.
-
Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation. Pediatrics. 1990 Apr; 85(4 Pt 2):698-704.
-
Decline in serum antibody to the capsule of Haemophilus influenzae type b in the immediate postimmunization period. J Pediatr. 1989 May; 114(5):742-7.
-
Response of infants to Haemophilus influenzae type b polysaccharide and diphtheria-tetanus-pertussis vaccines in combination. J Infect Dis. 1984 Jun; 149(6):950-5.
-
A COMPARISON OF IMMUNOGLOBULINS AND ANTIBODY PRODUCTION IN THE NORMAL AND THYMECTOMIZED MOUSE. J Immunol. 1964 Dec; 93:915-25.
-
ROLE OF THE THYMUS IN IMMUNE REACTIONS IN RATS. IV. IMMUNOGLOBULINS AND ANTIBODY FORMATION. Int Arch Allergy Appl Immunol. 1964; 25:206-24.